Brief: Lensar Receives U.S. FDA Clearance Of Ally Adaptive Cataract Treatment System

LENSAR

13/06/2022 12:21

June 13 (Reuters) - LENSAR Inc  LNSR.O :
    * LENSAR® RECEIVES U.S. FDA CLEARANCE OF ALLY™ ADAPTIVE
CATARACT
TREATMENT SYSTEM
    * LENSAR INC - COMPANY PLANS TO MAKE ALLY WIDELY AVAILABLE
TO
CATARACT SURGEONS IN 2023.

Source text for Eikon:  ID:nBw6lwRCLa 
Further company coverage:  LNSR.O 

 ((Reuters.Briefs@thomsonreuters.com;))